14,012 followers
Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C. https://t.co/8bTJxx0VqF
Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C. https://t.co/8bTJxx0VqF
Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors https://t.co/ttaAxbfEZD